Literature DB >> 33406484

Novel Markers of Recovery From Overtraining Syndrome: The EROS-LONGITUDINAL Study.

Flavio A Cadegiani, Pedro Henrique L Silva, Tatiana C P Abrao, Claudio E Kater.   

Abstract

PURPOSES: Overtraining syndrome (OTS) is an unexplained underperformance syndrome triggered by excessive training, insufficient caloric intake, inadequate sleep, and excessive cognitive and social demands. Investigation of the recovery process from OTS has not been reported to date. The objective was to unveil novel markers and biochemical and clinical behaviors during the restoration process of OTS.
METHODS: This was a 12-week interventional protocol in 12 athletes affected by OTS, including increase of caloric intake, transitory interruption of training, improvement of sleep quality, and management of stress, followed by the assessment of 50 parameters including basal and hormonal responses to an insulin tolerance test and nonhormonal biochemical markers, and body metabolism and composition.
RESULTS: Early cortisol (P = .023), late ACTH (adrenocorticotrophic hormone) (P = .024), and early and late growth hormone (P = .005 and P = .038, respectively) responses, basal testosterone (P = .038), testosterone:estradiol ratio (P = .0005), insulinlike growth factor 1 (P = .004), cortisol awakening response (P = .001), and free thyronine (P = .069) increased, while basal estradiol (P = .033), nocturnal urinary catecholamines (P = .038), and creatine kinase (P = .071) reduced. Conversely, markers of body metabolism and composition had slight nonsignificant improvements.
CONCLUSION: After a 12-week intervention, athletes affected by actual OTS disclosed a mix of non-, partial, and full recovery processes, demonstrating that remission of OTS is as complex as its occurrence.

Entities:  

Keywords:  athletes; burnout; paradoxical deconditioning syndrome; performance; underperformance

Mesh:

Substances:

Year:  2021        PMID: 33406484     DOI: 10.1123/ijspp.2020-0248

Source DB:  PubMed          Journal:  Int J Sports Physiol Perform        ISSN: 1555-0265            Impact factor:   4.010


  2 in total

1.  Potential risk for developing severe COVID-19 disease among anabolic steroid users.

Authors:  Flavio Cadegiani; Erica M Lin; Andy Goren; Carlos G Wambier
Journal:  BMJ Case Rep       Date:  2021-02-26

Review 2.  Diagnosing Overtraining Syndrome: A Scoping Review.

Authors:  Justin Carrard; Anne-Catherine Rigort; Christian Appenzeller-Herzog; Flora Colledge; Karsten Königstein; Timo Hinrichs; Arno Schmidt-Trucksäss
Journal:  Sports Health       Date:  2021-09-09       Impact factor: 4.355

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.